Shishe means "glass" in Farsi, a reference to the appearance of the
drug in some of its purest forms.
In less than a decade, methamphetamine use has skyrocketed in Iran
to the point where now about 345,000 Iranians are considered
addicts, according to official statistics.
Seizures of methamphetamine soared 128 percent between 2008 and
2012, topping all other countries in the region, according to
figures compiled by the United Nations Office on Drugs and Crime (UNODC).
Last year alone, the government of Iran confiscated 3.6 tonnes of
shishe.
A top official from the Iran Drug Control Headquarters said last
year that shishe could be found in Tehran in "less than five
minutes," according to the Iranian Students’ News Agency.
Shishe addicts in Iran are mostly urban, middle class and young,
experts say. Notably, there are a large number of women who abuse
shishe, too.
One of the main reasons why shishe use has spread quickly in Iran is
a lack of information about the drug, which has led casual users to
believe, erroneously, that it is not addictive, experts say.
Struggling university students have begun abusing it to stay up
longer and try to boost their performance in school. Women have been
sold the drug in beauty salons with the promise that it will help
them lose weight, according to local media reports.
"We really had a hard time convincing people that this is
addiction," said Azaraksh Mokri, a psychiatrist who teaches at the
Tehran University of Medical Sciences and has dealt extensively with
the issue of shishe addiction.
Opium addiction has long been a problem in Iran partly because of a
tolerance for its use even in conservative rural areas, and also
because of the country's long border with Afghanistan, for decades
one of the top opium producers. Opium is still the most abused drug
in Iran, according to official statistics.
INROADS
Shishe began to make inroads in the country about a decade ago,
luring users who preferred its effects as a stimulant to the more
soporific opium, which was seen as a drug of the poor and elderly.
That shift has been characterized as a change between drugs which
are known as sonati, or traditional, and those that are sanaati, or
manufactured, according to local media.
The use of shishe was partly driven by increased development in the
country and more complicated and faster-paced lifestyles, experts
say.
[to top of second column] |
Initially, the drug was imported but it later began to be produced
locally. UNODC figures show that the domestic use of pseudoephedrine,
one of the key ingredients for making shishe, jumped from five
tonnes in 2006 to 55 tonnes in 2012.
Drug use and addiction is so prevalent in Iran that it is the second
highest cause of death in the country after traffic accidents, a
senior official from the Iran Drug Control Headquarters said in
early November, according to the Islamic Republic News Agency.
Iran has some of the harshest drug laws in the region, regularly
executing smugglers and drug peddlers. At the same time, the country
has had a degree of success in the treatment of addiction, experts
say.
"Shishe is something that in a short time, in comparison to other
things, has very severe effects on behavior," said Said Kafrashi, an
advisory physician and therapist at the Aayandeh addiction
rehabilitation clinic in Tehran.
The clinic often tries to bring families of shishe addicts into the
rehabilitation process in order to examine all the social factors
that may have led to the drug use.
"The family plays a role here," said Kafrashi. "In light of the
individual's behavior, the family needs to change their behavior
too."
Still, despite some success in the treatment of shishe addiction,
Iran's battle with the drug is far from over.
"We need to do something so that they don't die, don't kill
themselves, don't kill others, and don't get psychosis so they can
mature out and get out," said Mokri.
(Reporting By Babak Dehghanpisheh; additional reporting by Fredrik
Dahl in Vienna; editing by Giles Elgood)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |